Similarly, the downregulated expression patterns of MEG3, DGCR5, and LINC-PINT recorded from our literature search also match with the expression data in our analysis of GBM clinical samples (0.11, 0.12, and 0.50-fold, respectively). This evidence concerns the gene LINC-PINT and glioblastoma.